Truist raised the firm’s price target on Omega Healthcare (OHI) to $39 from $38 and keeps a Hold rating on the shares. The firm is adjusting its model, assuming $600M of acquisitions in 2025 and $106M of dispositions. Truist also assumes $524 million of equity issuance in 2025 with proceeds applied toward repaying $400 million of maturing unsecured notes and $231 million of secured debt.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target lowered to $41 from $43 at Wells Fargo
- Omega Healthcare price target lowered to $39 from $43 at RBC Capital
- Omega Healthcare Reports Strong 2024 Financial Results
- Omega Healthcare’s Balanced Earnings Call Highlights
- Strong Q4 Performance and Strategic Moves Reinforce Buy Rating for Omega Healthcare